Some of the major trends driving the market are the rising cases of target diseases, growing geriatric population all over the world, and better healthcare initiatives by governments and various private organizations. An increase in the disposable incomes in many regions across the globe is an opportunity that this market could capitalize on and expand further in other regions of the world.
The global head and neck cancer diagnostics market has been segmented on the basis of various parameters. By type, it has been segmented into laryngeal and hypopharyngeal cancer, nasal cavity and paranasal sinus cancer, nasopharyngeal cancer, oral and oropharyngeal cancer, and salivary gland cancer. By diagnostic methods, the market has been further segmented into diagnostic imaging equipment, endoscopy screening equipment, bioscopy screening tests, blood tests, and dental diagnostic methods. Lastly, the market has also been segmented on the basis of geography into the Americas, Europe, Asia-Pacific, and Africa.
Africa and Asia-Pacific, along with parts of Europe and certain regions in South America, have the highest incidence of head and neck cancer cases. These regions are prone to higher intake of alcoholic and tobacco products, which could be instrumental in the rising cases of head and neck cancer cases in these regions. In Asia-Pacific and Africa, India, China, and South Africa are the biggest markets for the overall head and neck cancer diagnostics market.
This report explains the market growth and forecasts for the head and neck cancer diagnostics market, with a specific focus on the markets for diagnostic imaging, endoscopy, biopsy, blood tests, and dental diagnosis. The key drivers, restraints, and opportunities have been incorporated in the study, with a competitive analysis of the market captured simultaneously. The market size estimates have been forecasted for the year 2020 for both the global and regional markets.
Market analysis for the head and neck cancer diagnostics market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the global head and neck diagnostics market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Key Findings
1.2 Report Description
1.3 Research Methodologies
2. Market Forces
2.1 Market Drivers
2.1.1 Rise in Incidence of Target Diseases
2.1.2 Increasing Geriatric Population Worldwide
2.1.3 Better Government and Private Body Initiatives
2.2 Market Restraints
2.2.1 Low Adoption Rate of Digital Technology-Based Systems, Conventional CT, and MRI Scanners
2.2.2 Excise Duty Imposed on Sale of Medical Devices in Mature Markets
2.3.1 Large Target Patient Pool and Rise in Disposable Incomes in Emerging Economies
3. Head and Neck Cancer Market by types (predicted incidences by region till 2020)
3.1 Laryngeal and Hypopharyngeal Cancer
3.2 Nasal Cavity and Paranasal Sinus Cancer
3.3 Nasopharyngeal Cancer
3.4 Oral and Oropharyngeal Cancer
3.5 Salivary Gland Cancer
4. Global Head and Neck Cancer Diagnostic equipment Market (Market Size, Forecast, and CAGR)
4.1.1 Geographical market segmentation (Market Size, Forecast, and CAGR)
18.104.22.168 The Americas
4.2 Market Segmentation by Diagnostic methods (Market Size, Forecast, and CAGR)
4.2.1 Diagnostic Imaging Equipment
22.214.171.124 Barium Swallow test
4.2.2 Endoscopy Screening Equipment
4.2.3 Bioscopy Screening tests
126.96.36.199 Incisional Biopsy
188.8.131.52 Fine needle aspiration Biopsy
4.2.4 Blood Tests
184.108.40.206 Total cell count tests
220.127.116.11 Liver function test
18.104.22.168 EBV antibody measurement
4.2.5 Dental Diagnostic Methods
22.214.171.124 Fluorescence Visualization
126.96.36.199 Toluidine blue dye based method
188.8.131.52 Acetic acid rinse method
184.108.40.206 Brush biopsy
5. Competitive Landscape
5.1 New Product developments
5.2 Merger and Acquisitions
5.3 Collaborations, Agreements, Partnerships and Joint ventures
6. Company Profiles
6.1 Philips Healthcare
6.1.2 Major Products and services
6.1.3 Head and neck cancer screening-related developments
6.2 GE Healthcare
6.2.2 Major Products and services
6.2.3 Head and neck cancer screening-related developments
6.3 Siemens Healthcare
6.3.2 Major Products and services
6.3.3 Head and neck cancer screening-related developments
6.4 Varian Medical Systems
6.4.2 Major Products and services
6.4.3 Head and neck cancer screening-related developments
6.5 Shimadzu Corporation
6.5.2 Major Products and services
6.5.3 Head and neck cancer screening-related developments
6.6 AdDent Inc.
6.6.2 Major Products and services
6.6.3 Head and neck cancer screening-related developments
6.7.2 Major Products and services
6.7.3 Head and neck cancer screening-related developments
6.8 Velscope VX
6.8.2 Major Products and services
6.8.3 Head and neck cancer screening-related developments